Evidence map›Paper›PMID 17699673›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2007

Inositol triphosphate-mediated Ca2+ signals direct purinergic P2Y receptor regulation of neuronal ion channels.

Oleg Zaika, Gleb P Tolstykh, David B Jaffe, Mark S Shapiro

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 71 citations in OpenAlex.

  1. Calcium-sensing receptor regulates Kv7 channels via GBritish journal of pharmacology · 2024
    Article
  2. Involvement of CaCellular and molecular neurobiology · 2023
    Article
  3. Article
  4. Article
  5. Kv7 Channels and Excitability Disorders.Handbook of experimental pharmacology · 2021
    Article
  6. Article
  7. PIPInternational journal of molecular sciences · 2020
    Article
  8. Pharmacological Manipulation of KFrontiers in physiology · 2020
    Review
  9. Article
  10. Phosphatidylinositol 4,5-bisphosphate (PIPThe Journal of biological chemistry · 2018
    Article
  11. Article
  12. Article
  13. Review
  14. M-type KBritish journal of pharmacology · 2018
    Review
  15. Article
  16. Article
  17. Differential Regulation of PI(4,5)PFrontiers in molecular neuroscience · 2017
    Article
  18. P2Y Receptors Sensitize Mouse and Human Colonic Nociceptors.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  19. Dynamics of Phosphoinositide-Dependent Signaling in Sympathetic Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Oleg ZaikaDepartment of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA.
Gleb P Tolstykh
David B Jaffe
Mark S Shapiro
The University of Texas Health Science Center at San Antonio · USLaboratoire d’immunologie intégrative du cancer · FRThe University of Texas at San Antonio · US

Funding

Modulation of Neuronal Ion Channels by 2nd MessengersR01NS043394 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SHAPIRO, MARK S · 2002 to 2014
$4.5M
NINDS NIH HHS R01 NS043394NINDS NIH HHS R01 NS43394
6 · The paper itself

Abstract

Purinergic P2Y receptors are one of four types of G(q/11)-coupled receptors in rat superior cervical ganglia (SCG) sympathetic neurons. In cultured SCG neurons, purinergic and bradykinin suppression of I(M) were similar in magnitude and somewhat less than that by muscarinic agonists. The effects of the P2Y receptor agonist UTP on neuronal excitability and discharge properties were studied. Under current clamp, UTP increased action potential (AP) firing in response to depolarizing current steps, depolarized the resting potential, decreased the threshold current required to fire an AP, and decreased spike-frequency adaptation. These effects were very similar to those resulting from bradykinin stimulation and not as profound as from muscarinic stimulation or full M-current blockade. We then examined the P2Y mechanism of action. Like bradykinin, but unlike muscarinic, purinergic stimulation induced rises in intracellular [Ca(2+)](i). Tests using expression of IP(3)"sponge" or IP(3) phosphatase constructs implicated IP(3) accumulation as necessary for purinergic suppression of I(M). Overexpression of wild-type or dominant-negative calmodulin (CaM) implicated Ca(2+)/CaM in the purinergic action. Both sets of results were similar to bradykinin, and opposite to muscarinic, suppression. We also examined modulation of Ca(2+) channels. As for bradykinin, purinergic stimulation did not suppress I(Ca), unless neuronal calcium sensor-1 (NCS-1) activity was blocked by a dominant-negative NCS-1 construct. Our results indicate that P2Y receptors modulate M-type channels in SCG cells via IP(3)-mediated [Ca(2+)](i) signals in concert with CaM and not by depletion of phosphatidylinositol-4, 5-biphosphate. We group purinergic P2Y and bradykinin B(2) receptors together as having a common mode of action.

Indexed as

AnimalsAnimals, NewbornAnthracenesBradykininCalciumCalcium SignalingCells, CulturedComputer SimulationDose-Response Relationship, RadiationElectric StimulationInositol 1,4,5-TrisphosphateInositol PhosphatesIon ChannelsMaleMembrane PotentialsModels, Neurological10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenoneAnthracenesBradykininCalciumInositol 1,4,5-TrisphosphateInositol PhosphatesIon ChannelsReceptors, Purinergic P2Uridine Triphosphate

Identifiers

PMID17699673
PMCPMC6672180
OpenAlexW2045266599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.